Enrolling
Filter By:
Reporting
CTNPT 051: MindMap Feasibility Study
Optimizing HIV prevention for sexual and gender minorities seeking mental health supports: A feasibility study
Learn MoreOngoing
CTNPT 043: Endocannabinoid system and inflamm-aging in HIV-associated atherosclerosis
Interplay between expanded endocannabinoid (eCB) system and inflamm-aging: Implication for accelerated atherosclerosis in people living with HIV (PLWH) under ART
Learn MoreReporting
CTN 334: Sex Now / Test Now 2022
Barriers and Facilitators of the “Sex Now 2022” Venue-Based HIV Self-Testing and Peer-Based Linkage to Care Intervention for Sexual Minority Men, Non-Binary, and Two-Spirit People
Learn MoreCompleted
CTNPT 018: Adaptation and pilot of GPS among Latino gay positive men
Cultural Adaptation of Gay Poz Sex (GPS): A Positive Prevention Program for Gay, HIV-Positive Latino Men in Canada and Colombia
Learn MoreEnrolling
CTN 333: Sexual Health and HIV/AIDS: Longitudinal Women’s Needs Assessment (SHAWNA)
Longitudinal impacts of violence and stigma on HIV care continuum and broader health care access among women living with HIV
Learn MoreEnrolling
CTN 335: The British Columbia CARMA–CHIWOS Collaboration (BCC3)
The role of female sex hormones and chronic/latent co-infections on cellular aging and comorbidities in women living with HIV
Learn MoreReporting
CTN 328-1: Vaccine Confidence in HIV
Understanding COVID-19 vaccine confidence in people living with HIV in Canada: A pan-Canadian survey
Learn MoreEnrolling
CTNPT 047: Letermovir in ART-treated HIV-infected persons
Influence of a 3-month letermovir treatment on gut inflammation in ART-treated HIV-infected persons in an open labelled controlled randomized study
Learn More![Canadian Association for HIV Research](https://www.hivnet.ubc.ca/wp-content/uploads/2020/03/cahr-logo-1.png)
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.